학술논문
The New CHEST Guidelines on Antithrombotic Therapy for Atrial Fibrillation Should Consider Recent Data on Rivaroxaban
Document Type
Correspondence
Author
Source
In Chest June 2019 155(6):1309-1311
Subject
Language
ISSN
0012-3692